tbuckley/cabot-search huggingface dataset:
Well‐Defined Nanostructured Biointerfaces: Strengthened Cellular Interaction for Circulating Tumor Cells Isolation
Authors: Leixiao Yu, Peng Tang, Chuanxiong Nie, Yong Hou, Rainer Haag
Journal: Advanced Healthcare Materials (2021)

Abstract The topographic features at the cell–material biointerface are critical for cellular sensing of the extracellular environment (ECM) and have gradually been recognized as key factors that regulate cell adhesion behavior. Herein, a well‐defined nanostructured biointerface is fabricated via a new generation of mussel‐inspired polymer coating to mimic the native ECM structures. Upon the bioinert background presence and biospecific ligands conjugation, the affinity of cancer cells to the resulting biofunctional surfaces, which integrate topographic features and biochemical cues, is greatly strengthened. Both the conjugated bioligand density, filopodia formation, and focal adhesion expression are significantly enhanced by the surficial nano‐features with an optimized size‐scale. Thus, this nanostructured biointerface exhibits high capture efficiency for circulating tumor cells (CTCs) with high sensitivity, high biospecificity, and high purity. Benefiting from the unique bioligands conjugation chemistry herein, the captured cancer cells can be responsively detached from the biointerfaces without damage for downstream analysis. The present biofunctional nanostructured interfaces offer a good solution to address current challenges to efficiently isolate rare CTCs from blood samples for earlier cancer diagnosis.
Promoting Disclosure and Understanding in Informed Consent: Optimizing the Impact of the Common Rule “Key Information” Requirement
Authors: Kathryn M. Porter, Elliott M. Weiss, Stephanie A. Kraft
Journal: The American Journal of Bioethics (2021)

This article is referred to by:Response to Open Peer Commentaries on "Informed Consent: What Must Be Disclosed and What Must Be Understood?"
Schema: metric learning enables interpretable synthesis of heterogeneous single-cell modalities
Authors: Rohit Singh, Brian L. Hie, Ashwin Narayan, Bonnie Berger
Journal: Genome biology (2021)

A complete understanding of biological processes requires synthesizing information across heterogeneous modalities, such as age, disease status, or gene expression. Technological advances in single-cell profiling have enabled researchers to assay multiple modalities simultaneously. We present Schema, which uses a principled metric learning strategy that identifies informative features in a modality to synthesize disparate modalities into a single coherent interpretation. We use Schema to infer cell types by integrating gene expression and chromatin accessibility data; demonstrate informative data visualizations that synthesize multiple modalities; perform differential gene expression analysis in the context of spatial variability; and estimate evolutionary pressure on peptide sequences.
A Call to Action to Eliminate Indoor Tanning
Authors: Carolyn J. Heckman, David B. Buller, Jerod L. Stapleton
Journal: JAMA Dermatology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Dermatology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Dermatology journal
Propranolol for the treatment of ulcerated infantile hemangiomas: A prospective study
Authors: Yi Ji, Kaiying Yang, Jiangyuan Zhou, Xuepeng Zhang, Bo Xiang, Xian Jiang, Xuewen Xu, Tong Qiu, Shiyi Dai, Feiteng Kong, Guoyan Lu, Qingxia Qiu, Yongbo Zhang, Siyuan Chen
Journal: Journal of the American Academy of Dermatology (2021)
TREND AND PREDICTORS OF TAVI RELATED IN-HOSPITAL MORTALITY - A NATIONAL INPATIENT SAMPLE DATABASE
Authors: Waqas Ullah, Salman Zahid, David Fischman, Ihab Hamzeh, Yochai Birnbaum, Salim Virani, Mahboob Alam
Journal: Journal of the American College of Cardiology (2021)
Sixty seconds on . . . smell training
Authors: Abi Rimmer
Journal: BMJ (2021)

Essentially, it’s actively sniffing the same four scents every day for several months.1 The idea is that it can help you to recover your sense of smell if you’ve lost it for two weeks or more.

As you know, loss of smell, or olfactory dysfunction, is a common symptom of covid-19. Research has found that 60% of patients experience loss of smell within the …
Revitalizing Adolescent Health Behavior After the COVID-19 Pandemic
Authors: Sherry L. Pagoto, David E. Conroy
Journal: JAMA Pediatrics (2021)

Benjamin W. Chaffee, DDS, MPH, PhD; Jing Cheng, MD, MS, PhD; Elizabeth T. Couch, RDH, MS; Kristin S. Hoeft, MPH, PhD; Bonnie Halpern-Felsher, PhD
Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction
Authors: Meng Zhao, Yuji Nakada, Yuhua Wei, Weihua Bian, Yuxin Chu, Anton V. Borovjagin, Min Xie, Wuqiang Zhu, Thanh Nguyen, Yang Zhou, Vahid Serpooshan, Gregory P. Walcott, Jianyi Zhang
Journal: Circulation (2021)

Background: Human induced pluripotent stem cells with normal (wild-type) or upregulated (overexpressed) levels of CCND2 (cyclin D2) expression were differentiated into cardiomyocytes (CCND2 WT CMs or CCND2 OE CMs, respectively) and injected into infarcted pig hearts. Methods: Acute myocardial infarction was induced by a 60-minute occlusion of the left anterior descending coronary artery. Immediately after reperfusion, CCND2 WT CMs or CCND2 OE CMs (3×10 7 cells each) or an equivalent volume of the delivery vehicle was injected around the infarct border zone area. Results: The number of the engrafted CCND2 OE CMs exceeded that of the engrafted CCND2 WT CMs from 6- to 8-fold, rising from 1 week to 4 weeks after implantation. In contrast to the treatment with the CCND2 WT CMs or the delivery vehicle, the administration of CCND2 OE CM was associated with significantly improved left ventricular function, as revealed by magnetic resonance imaging. This correlated with reduction of infarct size, fibrosis, ventricular hypertrophy, and cardiomyocyte apoptosis, and increase of vascular density and arterial density, as per histologic analysis of the treated hearts. Expression of cell proliferation markers (eg, Ki67, phosphorylated histone 3, and Aurora B kinase) was also significantly upregulated in the recipient cardiomyocytes from the CCND2 OE CM-treated than from the CCND2 WT CM-treated pigs. The cell proliferation rate and the hypoxia tolerance measured in cultured human induced pluripotent stem cell cardiomyocytes were significantly greater after treatment with exosomes isolated from the CCND2 OE CMs (CCND2 OE Exos) than from the CCND2 WT CMs (CCND2 WT Exos). As demonstrated by our study, CCND2 OE Exos can also promote the proliferation activity of postnatal rat and adult mouse cardiomyocytes. A bulk miRNA sequencing analysis of CCND2 OE Exos versus CCND2 WT Exos identified 206 and 91 miRNAs that were significantly upregulated and downregulated, respectively. Gene ontology enrichment analysis identified significant differences in the expression profiles of miRNAs from various functional categories and pathways, including miRNAs implicated in cell-cycle checkpoints (G2/M and G1/S transitions), or the mechanism of cytokinesis. Conclusions: We demonstrated that enhanced potency of CCND2 OE CMs promoted myocyte proliferation in both grafts and recipient tissue in a large mammal acute myocardial infarction model. These results suggest that CCND2 OE CMs transplantation may be a potential therapeutic strategy for the repair of infarcted hearts.
GOING AGAINST THE ODDS - A CASE OF SUCCESS IN A PREGNANT PATIENT WITH COMPLEX CONGENITAL HEART DISEASE
Authors: Mylena Cristina Kormann-Moreira, Ana Vitória Vitoreti Martins, Stephanie Ondracek Lemouche, Marcela Devido Santana, Ana Cristina Sayuri Tanaka, Leina Zorzanelli, Ana Maria Thomaz, Nana Miura Ikari, Walkiria Samuel Avila
Journal: Journal of the American College of Cardiology (2021)
Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Authors: Kirsten L. Johansen, Pranav S. Garimella, Caitlin W. Hicks, Philip A. Kalra, Dearbhla M. Kelly, Sven Martens, Kunihiro Matsushita, Pantelis Sarafidis, Manish M. Sood, Charles A. Herzog, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer, Holger Reinecke, Zanfina Ademi, Tara I. Chang, Tim Clark, Chris Cooper, Michael Criqui, Áine de Bhailis, Marco De Carlo, Wolfram Döhner, Daniel T. Engelman, Gerry Fowkes, Darren Green, Allen Hamdan, Christian Heiss, Peter Huppert, Daniella Kadian-Dodov, Gregory Y.H. Lip, Jolanta Małyszko, Patrick B. Mark, Marius Miglinas, Patrick Murray, Chris Reid, Paul Rochon, Josiah Ruturi, Athanasios Saratzis, Mark J. Sarnak, Cathy M. Shanahan, Laura Solá, Ulf Teichgräber, Stephen C. Textor, Kazunori Toyoda, Angela Yee-Moon Wang, Chris X. Wong
Journal: Kidney International (2021)

Chronic kidney disease (CKD) affects about 10% of all populations worldwide, with about 2 million people requiring dialysis. Although patients with CKD are at high risk of cardiovascular disease and events, they are often underrepresented or excluded in clinical trials, leading to important knowledge gaps about how to treat these patients. KDIGO (Kidney Disease: Improving Global Outcomes) convened the fourth clinical Controversies Conference on the heart, kidney and vasculature in Dublin, Ireland, in February 2020, entitled Central and Peripheral Arterial Diseases in Chronic Kidney Disease. A global panel of multidisciplinary experts from the fields of nephrology, cardiology, neurology, surgery, radiology, vascular biology, epidemiology, and health economics attended. The objective was to identify key issues related to the optimal detection, management, and treatment of cerebrovascular diseases, central aortic disease, renovascular disease, and peripheral artery disease in the setting of CKD. This report outlines the common pathophysiology of these vascular processes in the setting of CKD, describes best practices for their diagnosis and management, summarizes areas of uncertainty, addresses ongoing controversial issues, and proposes a research agenda to address key gaps in knowledge that, when addressed, could improve patient care and outcomes.
LSE–Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19
Authors: Michael Anderson, Emma Pitchforth, Miqdad Asaria, Carol Brayne, Barbara Casadei, Anita Charlesworth, Angela Coulter, Bryony Dean Franklin, Cam Donaldson, Michael Drummond, Karen Dunnell, Margaret Foster, Ruth Hussey, Paul Johnson, Charlotte Johnston-Webber, Martin Knapp, Gavin Lavery, Marcus Longley, Jill Macleod Clark, Azeem Majeed, Martin McKee, John N Newton, Ciaran O'Neill, Rosalind Raine, Mike Richards, Aziz Sheikh, Peter Smith, Andrew Street, David Taylor, Richard G Watt, Moira Whyte, Michael Woods, Alistair McGuire, Elias Mossialos
Journal: The Lancet (2021)
Cell-Based Gene Therapy Is New Option for Multiple Myeloma
Authors: Rebecca Voelker
Journal: JAMA (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
RACIAL DIFFERENCES IN CLINICAL FEATURES AND OUTCOMES OF PATIENTS UNDERGOING HIGH RISK PCI WITH HEMODYNAMIC SUPPORT IN A CONTEMPORARY COHORT
Authors: Amir Kaki, Rami Zein, Chirdeep Patel, Theodore Schreiber, Thomas LaLonde, Ioana Ghiu, Cindy Grines, William O’Neill, Rajendra Mehta
Journal: Journal of the American College of Cardiology (2021)
PERICARDITIS WITH ASSOCIATED PERICARDIAL EFFUSION AND A POSSIBLE MYOCARDITIS TWO YEARS AFTER A SINGLE DOSE OF DURVALUMAB FOR TREATMENT OF LUNG CANCER
Authors: Oseiwe Benjamin Eromosele, Tochi Okwuosa, Muhammad Talha Ayub, Maria Isabel Planek
Journal: Journal of the American College of Cardiology (2021)
Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial
Authors: Anna Ockerman, Isabel Miclotte, Maarten Vanhaverbeke, Thomas Vanassche, Ann Belmans, Jan Vanhove, Joeri Meyns, Nasser Nadjmi, Geert Van Hemelen, Patrick Winderickx, Reinhilde Jacobs, Constantinus Politis, Peter Verhamme
Journal: PLoS Medicine (2021)

Background Oral bleeding after dental extraction in patients on non-vitamin K oral anticoagulants (NOACs) is a frequent problem. We investigated whether 10% tranexamic acid (TXA) mouthwash decreases post-extraction bleeding in patients treated with NOACs. Methods and findings The EXTRACT-NOAC study is a randomized, double-blind, placebo-controlled, multicenter, clinical trial. Patients were randomly assigned to 10% TXA or placebo mouthwash and were instructed to use the mouthwash once prior to dental extraction, and thereafter for 3 times a day for 3 days. The primary outcome was the number of patients with any post-extraction oral bleeding up to day 7. Secondary outcomes included periprocedural, early, and delayed bleeding, and the safety outcomes included all thrombotic events. The first patient was randomized on February 9, 2018 and the last patient on March 12, 2020. Of 222 randomized patients, 218 patients were included in the full analysis set, of which 106 patients were assigned to TXA (74.8 (±8.8) years; 81 men) and 112 to placebo (72.7 (±10.7) years; 64 men). Post-extraction bleeding occurred in 28 (26.4%) patients in the TXA group and in 32 (28.6%) patients in the placebo group (relative risk, 0.92; 95% confidence interval [CI], 0.60 to 1.42; P = 0.72). There were 46 bleeds in the TXA group and 85 bleeds in the placebo group (rate ratio, 0.57; 95% CI, 0.31 to 1.05; P = 0.07). TXA did not reduce the rate of periprocedural bleeding (bleeding score 4 ± 1.78 versus 4 ± 1.82, P = 0.80) and early bleeding (rate ratio, 0.76; 95% CI, 0.42 to 1.37). Delayed bleeding (rate ratio, 0.32; 95% CI, 0.12 to 0.89) and bleeding after multiple extractions (rate ratio, 0.40; 95% CI, 0.20 to 0.78) were lower in the TXA group. One patient in the placebo group had a transient ischemic attack while interrupting the NOAC therapy in preparation for the dental extraction. Two of the study limitations were the premature interruption of the trial following a futility analysis and the assessment of the patients’ compliance that was based on self-reported information during follow-up. Conclusions In patients on NOACs undergoing dental extraction, TXA does not seem to reduce the rate of periprocedural or early postoperative oral bleeding compared to placebo. TXA appears to reduce delayed bleeds and postoperative oral bleeding if multiple teeth are extracted. Trial registration ClinicalTrials.gov NCT03413891 EudraCT; EudraCT number: 2017-001426-17 ; EudraCT Public website: eudract.ema.europa.eu .
Diagnosis of Trichomoniasis
Authors: John N. Krieger
Journal: JAMA (1988)

The accuracy of (1) conventional wet-mount examination, (2) Papanicolaoustained gynecologic smears, (3) a direct slide test using fluorescein-conjugated monoclonal antibodies against<i>Trichomonas vaginalis</i>, and (4) two different culture media for the diagnosis of trichomoniasis in a high-risk population of 600 women was compared. Use of Feinberg-Whittington or Diamond's culture medium resulted in a diagnosis of 82 and 78 cases, respectively, and the combination of two cultures identified 88 infected women. In comparison, wet-mount examination detected only 53 (60%) of the cases. Cytologic smears were interpreted as positive for<i>T vaginalis</i>in 49 (56%) of the 88 cases but also resulted in seven false-positive smears, and specimens from 18 women with negative cultures were interpreted as "suspicious" for trichomoniasis. Monoclonal antibody staining detected 76 (86%) of the 88 positive specimens, including 27 (77%) of the 35 cases missed by wet-mount examination. In summary, wet-mount and cytologic studies were insensitive, and cytology study was the least specific method for diagnosis of trichomoniasis. Direct immunofluorescence with monoclonal antibodies holds promise as a sensitive and specific alternative to cultures for rapid detection of<i>T vaginalis</i>in clinical specimens. (<i>JAMA</i>1988;259:1223-1227)
INCREASED MEAN PLATELET VOLUME IS ASSOCIATED WITH INCREASED MORTALITY IN CARDIOGENIC SHOCK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH CIRCULATORY SUPPORT
Authors: Mohammad Hamza, Kajol Doshi, Misak Harutyunyan, Anish Adhikari, Haider Nazeer, Neil Yager, Mikhail Torosoff, Ulrich Jorde, Dmitri Belov
Journal: Journal of the American College of Cardiology (2021)
Uniform Requirements for Manuscripts Submitted to Biomedical Journals
Journal: JAMA (1993)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Treatment of Retinoblastoma 1–Intact Hepatocellular Carcinoma With Cyclin‐Dependent Kinase 4/6 Inhibitor Combination Therapy
Authors: Jindan Sheng, Susumu Kohno, Nobuhiro Okada, Nobuyuki Okahashi, Kana Teranishi, Fumio Matsuda, Hiroshi Shimizu, Paing Linn, Naoko Nagatani, Minako Yamamura, Kenichi Harada, Shin‐ichi Horike, Hiroshi Inoue, Seiji Yano, Sharad Kumar, Shunsuke Kitajima, Itsuki Ajioka, Chiaki Takahashi
Journal: Hepatology (2021)

Background and Aims Synthetic cyclin‐dependent kinase (CDK) 4/6 inhibitors exert antitumor effects by forcing RB1 in unphosphorylated status, causing not only cell cycle arrest but also cellular senescence, apoptosis, and increased immunogenicity. These agents currently have an indication in advanced breast cancers and are in clinical trials for many other solid tumors. HCC is one of promising targets of CDK4/6 inhibitors. RB family dysfunction is often associated with the initiation of HCC; however, this is revivable, as RB family members are not frequently mutated or deleted in this malignancy. Approach and Results Loss of all Rb family members in transformation related protein 53 ( Trp53 ) −/− mouse liver resulted in liver tumor reminiscent of human HCC, and re‐expression of RB1 sensitized these tumors to a CDK4/6 inhibitor, palbociclib. Introduction of an unphosphorylatable form of RB1 (RB7LP) into multiple liver tumor cell lines induced effects similar to palbociclib. By screening for compounds that enhance the efficacy of RB7LP, we identified an I kappa B kinase (IKK)β inhibitor Bay 11‐7082. Consistently, RB7LP expression and treatment with palbociclib enhanced IKKα/β phosphorylation and NF‐κB activation. Combination therapy using palbociclib with Bay 11‐7082 was significantly more effective in hepatoblastoma and HCC treatment than single administration. Moreover, blockade of IKK–NF‐κB or AKT pathway enhanced effects of palbociclib on RB1‐intact KRAS Kirsten rat sarcoma viral oncogene homolog mutated lung and colon cancers. Conclusions In conclusion, CDK4/6 inhibitors have a potential to treat a wide variety of RB1‐intact cancers including HCC when combined with an appropriate kinase inhibitor.
ANTI-PLATELET, OR ANTI-NEUTROPHIL? A CASE OF CLOPIDOGREL-INDUCED NEUTROPENIA
Authors: Steven Troy, Mina Botros, Cecillia Wong, Kyle Fraielli, Salwa Khedr, Nancy Skehan, Gerard Aurigemma, Colleen Harrington
Journal: Journal of the American College of Cardiology (2021)
Reasons for Admissions to US Children’s Hospitals During the COVID-19 Pandemic
Authors: Peter J. Gill, Sanjay Mahant, Matt Hall, Jay G. Berry
Journal: JAMA (2021)

This study uses Pediatric Health Information System database data to compare hospitalizations in US children's hospitals early in the COVID-19 pandemic (March-August 2020) vs the same period in 2017-2019, overall and for respiratory, chronic, nonrespiratory, and other conditions.
RACIAL DISPARITIES IN THE UTILIZATION AND IN-HOSPITAL OUTCOMES OF PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE AMONG PATIENTS WITH ATRIAL FIBRILLATION: PERSPECTIVES FROM THE NATIONAL INPATIENT SAMPLE
Authors: Louis Vincent, Iordan Potchileev, Jelani Grant, Bertrand Ebner, Jennifer Maning, Odunayo Olorunfemi, Neal Olarte, Rosario Colombo, Eduardo De Marchena
Journal: Journal of the American College of Cardiology (2021)
REAL-WORLD PATIENT CHARACTERSITICS AND SHORT-TERM FOLLOW-UP OF 9600 MITRACLIP IMPLANTATIONS - NATIONAL READMISSION DATABASE 2016-2017 INSIGHTS
Authors: Shubham Lahan, Sagar Ranka, Prakash Acharya, Amandeep Goyal, Peter Tadros, George Zorn, Mark Wiley, Kamal Gupta, Zubair Shah
Journal: Journal of the American College of Cardiology (2021)